- Cancer and Blood Diseases (10)
- Diabetes and Endocrinology (5)
- Fetal Care (3)
- Gastroenterology, Hepatology and Nutrition (10)
- Heart (21)
- Mental and Behavioral Health (10)
- Nephrology (4)
- Neurology and Neurosurgery (10)
- Orthopaedics (8)
- Perinatal (3)
- Pulmonary Medicine (8)
- Urology (5)
Search by Keyword
Results (10)
$1.48M State Grant Boosts ENGRAFT Learning Network
Ohio Gov. Mike DeWine stopped by Cincinnati Children’s on Dec. 5 to announce a major boost for pediatric cancer research—a $1.48 million grant to power the ENGRAFT learning network. This collaborative effort brings together experts, families, and partners to transform outcomes for kids needing stem cell transplants, as part of a $5 million statewide investment in fighting childhood cancer.
A Bold Investment to Make the Future of Medicine Happen
The new Applied Gene and Cell Therapy Center will expand capacity for manufacturing viral vectors and cell-based products under Current Good Manufacturing Practice conditions, supporting complex trials in oncology, hematology and rare genetic disorders, with capabilities for large-scale bioreactor production and post-approval therapy manufacturing.
Advancements Bring New Hope for Sickle Cell Disease
A Phase II clinical trial conducted in Ghana suggests that hydroxyurea — already a treatment offered for the most common form of sickle cell disease — also shows benefits for those with the hemoglobin SC (HbSC) variant of the condition.
Advancements Bring New Hope for Sickle Cell Disease
Cincinnati Children’s researchers present new findings on sickle cell disease, highlighting underused therapies and promising advances in treatment options.
Advancing Gene Therapy in Pediatric Hematology and Oncology
Cincinnati Children’s advances telomere elongation therapy for rare marrow failure syndromes, supported by its Applied Gene and Cell Therapy Center—a new hub designed to speed gene and cell therapy breakthroughs from research to patient care.
Advancing Lifesaving Therapies for Myeloid Malignancies
Discover how Cincinnati Children’s is accelerating research and clinical trials to advance therapies for myeloid malignancies across all age groups.
Cincinnati Children’s Launches ENGRAFT Network
ENGRAFT, a new learning health network led by Cincinnati Children’s, brings together pediatric and adult centers to improve transplant and cellular therapy outcomes.
Expanding Expertise with 10 New Faculty in Pediatric Cancer and Blood Disorders
Meet the experts joining the Cancer and Blood Diseases Institute to advance care and research in pediatric oncology, hematology, bone marrow transplantation and proton therapy.
New Faculty Advance Pediatric Cancer and Blood Disease Care
Specialists in oncology, hematology, bone marrow transplantation and proton therapy join the Cancer and Blood Diseases Institute to enhance precision medicine and multidisciplinary care.
Novel Tests for Pediatric Cancer Diagnosis and Monitoring
Cincinnati Children’s unveils advanced genomic tools for pediatric cancer care—CinCSeq and Histiotrak offer faster, more precise diagnostics and monitoring.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
